IHT Wealth Management’s NanoViricides NNVC Stock Holding History

IHT Wealth Management’s Portfolio NNVC Stock Details NNVC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-2,321	Closed	-$11K	–	628
2019 Q2	$11K	Sell	2,321 -44	-2%	-$226	﹤0.01%	544
2019 Q1	$13K	Buy	+2,365	New	+$15.4K	﹤0.01%	513
2018 Q4	–	Sell	-2,431	Closed	-$18K	–	504
2018 Q3	$18K	Hold	2,431	–	–	﹤0.01%	426
2018 Q2	$21K	Hold	2,431	–	–	0.01%	408
2018 Q1	$39K	Hold	2,431	–	–	0.01%	757
2017 Q4	$45K	Hold	2,431	–	–	0.01%	730
2017 Q3	$53K	Buy	2,431 +77	+3%	+$2.07K	0.02%	508
2017 Q2	$0	Buy	2,354 +89	+4%	+$2.2K	﹤0.01%	1447
2017 Q1	$50K	Buy	2,265 +547	+32%	+$12.8K	0.03%	419
2016 Q4	$38K	Buy	+1,718	New	+$45.8K	0.03%	445

Other funds holding NNVC

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BCWM

Bartlett & Co Wealth Management Cincinnati, Ohio $7.99B AUM 20.76% 1-Year Est. Return

Bartlett & Co Cincinnati, Ohio $6.16B AUM 20.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

IHT Wealth Management's NNVC Position: Q3 2019 in Review

IHT Wealth Management sold out of NanoViricides (NNVC) in Q3 2019, closing a stake of 2,321 shares — an estimated $11K sold.

IHT Wealth Management first reported a position in NNVC in Q4 2016 and held it in 10 quarters. The position peaked at $53K in Q3 2017. 17 funds tracked by Wall St. Rank hold NNVC as of Q3 2019.

IHT Wealth Management reported no remaining NanoViricides position as of Q3 2019 after selling out during the quarter.
IHT Wealth Management sold 2,321 NanoViricides shares in Q3 2019, an estimated $11K.
IHT Wealth Management first reported a position in NanoViricides in Q4 2016 and held it in 10 quarters.
IHT Wealth Management's NanoViricides position peaked at $53K in Q3 2017.
17 funds tracked by Wall St. Rank held NanoViricides as of Q3 2019.

Based on IHT Wealth Management's 13F filing for Q3 2019, filed 15 Nov 2019.